Infectious Disease · Internal Medicine · 3 h ago
Appropriate Empirical Antibiotics Linked to Better ICU Outcomes in DIANA Analysis
A commentary discusses a predefined observational sub-analysis of the international DIANA study involving 845 critically ill patients with microbiologically confirmed infections. Appropriate empirical antimicrobial therapy was associated with improved survival and more antimicrobial-free and ventilator-free days, although broad-spectrum use and residual confounding limit interpretation.
- Appropriate therapy was used in 87.7% of 845 patients.
- Therapy was associated with improved survival (adjusted OR 1.83).
- Associations were strongest at SOFA scores of 3–9.
- Observational results do not justify indiscriminate broad-spectrum use.
A predefined sub-analysis of the international DIANA study examined 845 critically ill patients with microbiologically confirmed infections. Appropriate empirical antibiotic therapy was given in 87.7% of cases. The analysis assessed associations between therapy appropriateness and patient outcomes; culture-negative infections were excluded because appropriateness could not be determined for them.
Appropriate empirical therapy was independently associated with improved survival (adjusted odds ratio, 1.83) and with more antimicrobial-free and mechanical ventilation-free days. The reported survival association was strongest among patients with SOFA scores of 3–9. The commentary notes that the absence of a statistically significant difference in the highest-severity group (SOFA >9) may reflect limited statistical power.
These observational findings support an association, not proof that appropriate therapy caused better outcomes. The authors also caution against equating appropriate coverage with indiscriminate broad-spectrum prescribing: the high rate of appropriateness may have reflected frequent combination and broad-spectrum treatment, which can carry harms. They argue for tailoring empirical choices to local resistance patterns and patient factors, followed by reassessment; the analysis does not establish a new prescribing protocol.
In practice
For critically ill patients with microbiologically confirmed infection, the DIANA sub-analysis found that appropriate empirical antimicrobial therapy was associated with improved survival and more antimicrobial-free and ventilator-free days; the reported survival association was strongest at SOFA scores of 3–9. These findings are observational and do not establish causality or a specific prescribing strategy. Appropriateness should not be taken to mean maximal broad-spectrum coverage, which may cause harm; the study excluded culture-negative infections.
AI-generated clinical interpretation · Not editor-reviewed
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
Intensive Care Medicine: Beyond avoiding failure: the proactive and beneficial role of appropriate antimicrobial therapy in the ICU ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.